¥484.47
Above FV▼ -58.9% against the close used
Model range ¥93.88 – ¥613.60
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Bear¥93.88Fair value¥484.47Bull¥613.60
FairClose
52-week traded range
52W low ¥835.0052W high ¥1,535.00
The 52-week range is measured from the stored price history, not estimated.
Trading above the consensus fair value
GMO PRIME STRATEGY CO.,LTD. closed at ¥1,178.00, 143.2% above the consensus fair value of ¥484.47 drawn from 9 valuation models.
Financial DNA score 49/100 — Average. P/E of 38.4x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
DCF Valuation
¥463.72
-60.6%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=3.1%, r=10%, tg=3%, n=10yr
Graham Number
¥528.62
-55.1%
√(22.5 × EPS × BVPS)
EPS=30.68, BVPS=404.81 · outside Graham range (P/E 38.4, P/B 2.9) — asset-light, treat as a rough floor
P/E Fair Value
¥613.60
-47.9%
EPS × 20x (sector P/E)
EPS=30.68, Sector P/E=20x
Peter Lynch (PEG)
¥93.88
-92.0%
EPS × Growth% (PEG = 1 is fair)
EPS=30.68, g=3.1%
EV/EBITDA
¥503.19
-57.3%
(EBITDA × 11.5x − Net Debt) ÷ Shares
EBITDA=155.52M
Dividend Discount (DDM)
¥327.13
-72.2%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=22.03, r=10%, g=3.1%
Book Value (P/B)
¥264.82
-77.5%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=404.81, ROE=7.6%, g=3.1%, r=10%
Reverse DCF
¥1,178.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 15.9% | Historical: 3.1%
Margin of Safety
¥401.49
-65.9%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=535.31, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.